Notch4′s high mRNA expression was also found to be significantly correlated to worsen OS for all gastric cancer patients, HR 1.98 (1.64–2.4), p = 9.3e-13 (Fig. 4A), intestinal type cancer patients, HR 2.47 (1.77–3.64), p = 4.6e-08 (Fig. 4B), and diffuse type cancer patients, HR 1.81 (1.18–2.76), p = 0.0054 (Fig. 4C). Here, NOTCH4 is linked to gastric cancer.